| Summary | ||||||||
|
Mutation origin |
|
|||||||
|
Mutation description |
|
|||||||
| Find Mice (IMSR) |
|
|||||||
| Notes |
Induced by thiophosphamide (thio-TEPA, thio-TEPA). Inbred lines differ in sensitivity to the chemical mutagen thiophosphamide based on the frequencies of chromosomal aberrations found in bone marrow cells after TEPA treament. The 101/H and C57BL/6J strains were among those with greater sensitivity, while C3H/Sn and CBA/Lac were relatively insensitive.
Cytogenetic effects of TEPA on bone marrow cell chromosomes from backcrosses of sensitive with nonsensitive lines were studied, using (C3H x 101)F1 x 101 and (CBA x C57BL/6)F1 x C57BL/6 backcrosses. Two classes of progeny differing significantly in frequency of cells with aberrations were found in each backcross. Results were interpreted to indicate the occurrence of a mut1 in the 101 strain and a mut2 mutation in C57BL/6, each increasing the frequency of aberrations caused by TEPA treatment (J:4476).
|
|||||||
| References |
|
|||||||
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 01/28/2026 MGI 6.24 |
|
|
|
||